These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 38489072)

  • 1. Psoralen: a narrative review of current and future therapeutic uses.
    Galiatsatos P; Maydan DD; Macalpine E; Schleupner B; Aitchison AH; Lerner AD; Levy B; Halthore A; Eward W
    J Cancer Res Clin Oncol; 2024 Mar; 150(3):130. PubMed ID: 38489072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. X-Ray Psoralen Activated Cancer Therapy (X-PACT).
    Oldham M; Yoon P; Fathi Z; Beyer WF; Adamson J; Liu L; Alcorta D; Xia W; Osada T; Liu C; Yang XY; Dodd RD; Herndon JE; Meng B; Kirsch DG; Lyerly HK; Dewhirst MW; Fecci P; Walder H; Spector NL
    PLoS One; 2016; 11(9):e0162078. PubMed ID: 27583569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psoralens potentiate ultraviolet light-induced inhibition of epidermal growth factor binding.
    Laskin JD; Lee E; Laskin DL; Gallo MA
    Proc Natl Acad Sci U S A; 1986 Nov; 83(21):8211-5. PubMed ID: 3490664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutagenicity of cross-links and monoadducts of furocoumarins (psoralen and angelicin) induced by 360-nm radiation in excision-repair-defective and radiation-insensitive strains of Saccharomyces cerevisiae.
    Grant EL; von Borstel RC; Ashwood-Smith MJ
    Environ Mutagen; 1979; 1(1):55-63. PubMed ID: 399905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psoralen Derivatives with Enhanced Potency.
    Buhimschi AD; Gooden DM; Jing H; Fels DR; Hansen KS; Beyer WF; Dewhirst MW; Walder H; Gasparro FP
    Photochem Photobiol; 2020 Sep; 96(5):1014-1031. PubMed ID: 32221980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and characterization of new psoralen derivatives with superior photoreactivity with DNA and RNA.
    Isaacs ST; Shen CK; Hearst JE; Rapoport H
    Biochemistry; 1977 Mar; 16(6):1058-64. PubMed ID: 849407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psoralen Derivatives: Recent Advances of Synthetic Strategy and Pharmacological Properties.
    Jamalis J; Yusof FSM; Chander S; Wahab RA; P Bhagwat D; Sankaranarayanan M; Almalki F; Hadda TB
    Antiinflamm Antiallergy Agents Med Chem; 2020; 19(3):222-239. PubMed ID: 31241020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repair of psoralen plus near ultraviolet light damage in bacteriophage T4.
    Zerler BR; Wallace SS
    Photochem Photobiol; 1979 Sep; 30(3):413-6. PubMed ID: 390566
    [No Abstract]   [Full Text] [Related]  

  • 9. Psoralen-DNA photoreaction: controlled production of mono- and diadducts with nanosecond ultraviolet laser pulses.
    Johnston BH; Johnson MA; Moore CB; Hearst JE
    Science; 1977 Aug; 197(4306):906-8. PubMed ID: 887929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psoralen: A Biologically Important Coumarin with Emerging Applications.
    Thakur A; Sharma R; Jaswal VS; Nepovimova E; Chaudhary A; Kuca K
    Mini Rev Med Chem; 2020; 20(18):1838-1845. PubMed ID: 32348216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psoralen-DNA crosslink repair in human lymphocytes. Comparison of alkaline elution with electron microscopy.
    Bohr V; Nielsen PE
    Biochim Biophys Acta; 1984 Nov; 783(2):183-6. PubMed ID: 6498201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photoreactivity of furocoumarins and DNA in PUVA therapy: formation of psoralen-thymine adducts.
    Serrano-Pérez JJ; Merchán M; Serrano-Andrés L
    J Phys Chem B; 2008 Nov; 112(44):14002-10. PubMed ID: 18855465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of action of psoralens: isobologram analysis reveals that ultraviolet light potentiation of psoralen action is not additive but synergistic.
    Yurkow EJ; Laskin JD
    Cancer Chemother Pharmacol; 1991; 27(4):315-9. PubMed ID: 1998988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid characterization of cross-links, mono-adducts, and non-covalent binding of psoralens to deoxyoligonucleotides by LC-UV/ESI-MS and IRMPD mass spectrometry.
    Smith SI; Brodbelt JS
    Analyst; 2010 May; 135(5):943-52. PubMed ID: 20419242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evolution of photochemotherapy with psoralens and UVA (PUVA): 2000 BC to 1992 AD.
    Pathak MA; Fitzpatrick TB
    J Photochem Photobiol B; 1992 Jun; 14(1-2):3-22. PubMed ID: 1432383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the induction of pyrimidine cyclobutane dimers relevant for the high cytotoxic effect of 7-methylpyrido[3,4-c]psoralen plus UV-A?
    Nocentini S
    Mutat Res; 1990 May; 235(3):203-7. PubMed ID: 2342507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-impermeant pyridinium derivatives of psoralens as inhibitors of keratinocyte growth.
    Mariano TM; Vetrano AM; Gentile SL; Heck DE; Whittemore MS; Guillon CD; Jabin I; Rapp RD; Heindel ND; Laskin JD
    Biochem Pharmacol; 2002 Jan; 63(1):31-9. PubMed ID: 11754871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photo-activated psoralen binds the ErbB2 catalytic kinase domain, blocking ErbB2 signaling and triggering tumor cell apoptosis.
    Xia W; Gooden D; Liu L; Zhao S; Soderblom EJ; Toone EJ; Beyer WF; Walder H; Spector NL
    PLoS One; 2014; 9(2):e88983. PubMed ID: 24551203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutagenic activity of four furocoumarins: angelicin, 4,5'-dimethyl-angelicin, psoralen and 8-methyl-psoralen on V79 Chinese hamster cells.
    Babudri N; Pani B; Venturini S; Monti-Bragadin C
    J Environ Pathol Toxicol Oncol; 1986; 7(1-2):123-9. PubMed ID: 3540276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psoralen/UV inactivation of HIV-1-infected cells for use in cytologic and immunologic procedures.
    Watson AJ; Klaniecki J; Hanson CV
    AIDS Res Hum Retroviruses; 1990 Apr; 6(4):503-13. PubMed ID: 2340205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.